Skip to Content
  1. All Products
  2. All Products
  3. NGL Unit 3, India, 2025
-
NGL Unit 3, India, 2025

NGL Unit 3, India, 2025

https://www.myauditor.nl/web/image/product.template/7571/image_1920?unique=14fcff6

GMP Audit Report

Company
NGL Fine Chem Ltd Unit 3

Product(s)
Buparvaquone, Carprofen, Clorsulon, Diminazene Diaceturate, Diminazene Diaceturate Granules, Flunixin Meglumine, Imidocarb Dipropionate, Marbofloxacin , Praziquantel , Toltrazuril ,  Xylazine Hydrochloride

Country
India

Audit Year
2025


0.00 € 0.0 EUR 0.00 €

0.00 €

This combination does not exist.

Request Quotation
Buparvaquone Carprofen Closuron Diminazene Diaceturate Diminazene Diaceturate Granules Flunixin Meglumine Imidocarb Dipropionate Marbofloxacin Praziquantel Toltrazuril Xylazine HCl

 

Share